1 / 10

United States Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Emerging

Amid the COVID-19 crisis, the United States market for non invasive prenatal testing (NIPT) estimated at US$ 788 million in the year 2021, is expected to reach a revised market size of US$ 2,557 Million by 2030, growing at a CAGR of 13.9% over the period 2021 u2013 2030.<br><br>The Prominent Factors that are Expected to Contribute to the Growth of the United States Non-Invasive Prenatal Testing Market During the Forecast Period:<br>increase in incidences of chromosomal aneuploidies among fetus<br>progress of advanced non-invasive prenatal testing products<br>rising adoption regarding non-invasive prenatal testin

dpiresearch
Download Presentation

United States Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Emerging

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. United States Non-Invasive Prenatal Testing (NIPT) Market  Update on the Market Share, Trends, Demand, Growth Potential, Opportunity, and progress

  2. Market Update “Amid the COVID-19 crisis, the United States market for non invasive prenatal testing (NIPT) estimated at US$ 788 million in the year 2021, is expected to reach a revised market size of US$ 2,557 Million by 2030, growing at a CAGR of 13.9% over the period 2021 – 2030”

  3. increase in incidences of chromosomal aneuploidies among fetus • progress of advanced non-invasive prenatal testing products • rising adoption regarding non-invasive prenatal testing • growing focus on reimbursement for non-invasive prenatal testing • increasing preference for non-invasive techniques over invasive methods • ACOG guidelines recommend NIPT for all pregnancies regardless of risk Market Description The Prominent Factors that are Expected to Contribute to the Growth of the United States Non-Invasive Prenatal Testing Market During the Forecast Period:

  4. Market Description After conducting thorough research on the historical and current growth parameters, the growth prospects of the United States non-invasive prenatal testing (NIPT) market are obtained with maximum precision. This new 2022 market report provides a holistic analysis of the entire United States non-invasive prenatal testing market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the United States’ non-invasive prenatal testing market. The report also provides up–to–date historical market size data for the period 2018 – 2021 and an illustrative forecast to 2030 covering key market aspects like market value and volume for non-invasive prenatal testing in the United States. The report also includes the latest insights on comparative test analysis by companies. The following points are covered in the comparative test analysis: technology, fetal fraction, starting week, twin, sex chromosome aneuploidy, gender, deletion/duplication, triploidy, turnaround time, egg donor, accuracy, and many more.

  5. Market Description Additionally, this up-to-date report describes the latest features reimbursement pattern and offers a clear view of the regulatory framework of the United States non–invasive prenatal testing market. The report also tracks and analyses competitive developments, including collaboration deals, mergers & acquisitions, venture capital investment, distribution, exclusive and licensing agreements, and partnerships deals. The report also covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market. The report will serve as a source for a 360-degree analysis, thoroughly integrating different models.

  6. Reports Delivers

  7. Industry Overview 49% 91% This slide is 100% editable. Adapt it to your needs and capture your audience's attention. This slide is 100% editable. Adapt it to your needs and capture your audience's attention. This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

  8. Competitive Analysis The Key Market Players for the United States Non–Invasive Prenatal Testing Market are Listed Below: • Illumina, Inc. • Natera, Inc. • Quest Diagnostics • Myriad Genetics, Inc. • Centogene • GenPath • PerkinElmer • Yourgene Health • Invitae Corporation • Agilent Technologies • Ariosa Diagnostics (Roche) • Laboratory Corporation of America Holdings

  9. What is the current scenario of the united states non–invasive prenatal testing market? • What is the total market size and forecast (until 2030) for the united states non–invasive prenatal testing market? • How big is the united states NIPT tests market? • Which is the best non-invasive prenatal test? • How has the potential market performed so far and how will it perform in the coming years? • How many NIPT tests are being performed in the united states during 2018 – 2030? • What is the market size of the average risk NIPT tests in the united states? • What is the market size of the high-risk NIPT tests in the united states? Key Questions Answered in this Report:

  10. Thank you Maria Rai +91 7667648693 sales@dpiresearch.com DPI Research

More Related